Standout Papers

Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tu... 2002 2026 2010 2018 840
  1. Sarcopenia as a Determinant of Chemotherapy Toxicity and Time to Tumor Progression in Metastatic Breast Cancer Patients Receiving Capecitabine Treatment (2009)
    Carla M. Prado, Vickie E. Baracos et al. Clinical Cancer Research
  2. Effects of Aerobic and Resistance Exercise in Breast Cancer Patients Receiving Adjuvant Chemotherapy: A Multicenter Randomized Controlled Trial (2007)
    Kerry S. Courneya, Roanne Segal et al. Journal of Clinical Oncology
  3. Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma: a phase III, double-blind, comparative trial. (2002)
    Lee S. Rosen, David Gordon et al. PubMed
  4. Long‐term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma (2003)
    Lee S. Rosen, David Gordon et al. Cancer
  5. Trastuzumab Plus Anastrozole Versus Anastrozole Alone for the Treatment of Postmenopausal Women With Human Epidermal Growth Factor Receptor 2–Positive, Hormone Receptor–Positive Metastatic Breast Cancer: Results From the Randomized Phase III TAnDEM Study (2009)
    Bella Kaufman, John R. Mackey et al. Journal of Clinical Oncology
  6. Randomized Controlled Trial of Exercise Training in Postmenopausal Breast Cancer Survivors: Cardiopulmonary and Quality of Life Outcomes (2003)
    Kerry S. Courneya, John R. Mackey et al. Journal of Clinical Oncology
  7. Metabolic Modulation of Glioblastoma with Dichloroacetate (2010)
    Evangelos D. Michelakis, Gopinath Sutendra et al. Science Translational Medicine
  8. Gastric Adenocarcinoma (2005)
    Bryan J. Dicken, David L. Bigam et al. Annals of Surgery
  9. Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer (2008)
    Evangelos D. Michelakis, Leeann Webster et al. British Journal of Cancer
  10. Incident Cardiovascular Disease Among Adults With Cancer (2022)
    D. Ian Paterson, Natasha Wiebe et al. JACC CardioOncology

Immediate Impact

11 by Nobel laureates 8 from Science/Nature 70 standout
Sub-graph 1 of 22

Citing Papers

Shining New Light on Biological Systems: Luminescent Transition Metal Complexes for Bioimaging and Biosensing Applications
2024 Standout
The design of small-molecule prodrugs and activatable phototherapeutics for cancer therapy
2023 Standout
4 intermediate papers

Works of John R. Mackey being referenced

Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
2008 Standout
Nucleoside transporters: molecular biology and implications for therapeutic development
1999
and 8 more

Author Peers

Author Last Decade Papers Cites
John R. Mackey 14473 5741 3908 4467 328 23.9k
Dawn L. Hershman 12299 2227 3435 3730 697 26.2k
Karen A. Gelmon 15458 5516 6840 6371 389 23.1k
Towia A. Libermann 6951 12889 3918 2332 265 27.3k
Hyman B. Muss 16825 2827 9175 5544 550 29.0k
Jeffrey A. Meyerhardt 15863 5183 3837 4124 425 25.0k
Howard L. McLeod 9953 9356 2829 2545 476 26.0k
Paul P. Carbone 10845 2656 2674 5376 219 24.3k
Clifford A. Hudis 23054 8120 13808 6733 509 38.8k
Kathleen I. Pritchard 15195 5962 9674 5236 368 24.8k
Alona Muzikansky 10163 4304 3233 5259 271 22.9k

All Works

Loading papers...

Rankless by CCL
2026